Systemic adverse events following rituximab therapy in patients with Graves' disease.

Journal of endocrinological investigation

Volumn 34, Issue 7, 2011, Pages

  El Fassi, D ^a   Nielsen, C H ^b   Junker, P ^b   Hasselbalch, H C ^b   Hegedus L ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; ANTITHYROID AGENT; MONOCLONAL ANTIBODY; RITUXIMAB; THIAMAZOLE;

ADULT; ANIMAL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGEN-ANTIBODY COMPLEX; ANTIRHEUMATIC AGENTS; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; METHIMAZOLE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 82655167232     PISSN: None     EISSN: 17208386     Source Type: Journal    
DOI: None     Document Type: Article

References (0)